Search research articles
Contact Us
Filters
Showing results (101-110 of 171) with videos related to
Page
of 18
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
October 9, 2001
Local delivery of c-myc neutrally charged antisense oligonucleotides with transport catheter inhibits myointimal hyperplasia and positively affects vascular remodeling in the rabbit balloon injury model
N Kipshidze, E Keane, D Stein, et al.
Scientific Reports
|
November 19, 2020
A novel patient-derived orthotopic xenograft (PDOX) mouse model of highly-aggressive liver metastasis for identification of candidate effective drug-combinations
Zhiying Zhang, Kaiwen Hu, Kentaro Miyake, et al.
Frontiers in Oncology
|
May 26, 2023
Activity of TNT: a phase 2 study using talimogene laherparepvec, nivolumab and trabectedin for previously treated patients with advanced sarcomas (NCT# 03886311)
Sant P Chawla, Walter Andree Tellez, Hripsime Chomoyan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 4, 2014
Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma
Sant P Chawla, Lee D Cranmer, Brian A Van Tine, et al.
Targeted Oncology
|
May 13, 2014
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab
Josep Tabernero, Sant P Chawla, Hedy Kindler, et al.
Cancer
|
April 25, 2003
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting
Sant P Chawla, Steven M Grunberg, Richard J Gralla, et al.
Biochemical and Biophysical Research Communications
|
April 9, 2019
Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse model
Takashi Higuchi, Kentaro Miyake, Hiromichi Oshiro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2022
Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study
Federico Longo-Muñoz, Daniel Castellano, Jerome Alexandre, et al.
Circulation
|
October 10, 2001
Effect of short pulsed nonablative infrared laser irradiation on vascular cells in vitro and neointimal hyperplasia in a rabbit balloon injury model
N Kipshidze, V Nikolaychik, M Muckerheidi, et al.
Anticancer Research
|
August 2, 2019
Sorafenib and Palbociclib Combination Regresses a Cisplatinum-resistant Osteosarcoma in a PDOX Mouse Model
Takashi Higuchi, Norihiko Sugisawa, Kentaro Miyake, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 171) with videos related to
Sort By:
Page
of 18
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
October 9, 2001
Local delivery of c-myc neutrally charged antisense oligonucleotides with transport catheter inhibits myointimal hyperplasia and positively affects vascular remodeling in the rabbit balloon injury model
N Kipshidze, E Keane, D Stein, et al.
Scientific Reports
|
November 19, 2020
A novel patient-derived orthotopic xenograft (PDOX) mouse model of highly-aggressive liver metastasis for identification of candidate effective drug-combinations
Zhiying Zhang, Kaiwen Hu, Kentaro Miyake, et al.
Frontiers in Oncology
|
May 26, 2023
Activity of TNT: a phase 2 study using talimogene laherparepvec, nivolumab and trabectedin for previously treated patients with advanced sarcomas (NCT# 03886311)
Sant P Chawla, Walter Andree Tellez, Hripsime Chomoyan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 4, 2014
Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma
Sant P Chawla, Lee D Cranmer, Brian A Van Tine, et al.
Targeted Oncology
|
May 13, 2014
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab
Josep Tabernero, Sant P Chawla, Hedy Kindler, et al.
Cancer
|
April 25, 2003
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting
Sant P Chawla, Steven M Grunberg, Richard J Gralla, et al.
Biochemical and Biophysical Research Communications
|
April 9, 2019
Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse model
Takashi Higuchi, Kentaro Miyake, Hiromichi Oshiro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2022
Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study
Federico Longo-Muñoz, Daniel Castellano, Jerome Alexandre, et al.
Circulation
|
October 10, 2001
Effect of short pulsed nonablative infrared laser irradiation on vascular cells in vitro and neointimal hyperplasia in a rabbit balloon injury model
N Kipshidze, V Nikolaychik, M Muckerheidi, et al.
Anticancer Research
|
August 2, 2019
Sorafenib and Palbociclib Combination Regresses a Cisplatinum-resistant Osteosarcoma in a PDOX Mouse Model
Takashi Higuchi, Norihiko Sugisawa, Kentaro Miyake, et al.
Page
of 18